AzTrials
AzTrials

Perinatal AnxietyNCT07757243

Mindfulness for Perinatal Distress

A study testing Group Mindfulness Intervention, Group Discussion and Routine Health Education in people with Perinatal Anxiety, run by Shenzhen Kangning Hospital at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled intervention study evaluated an 8-week group mindfulness intervention for pregnant women at 20 to 30 gestational weeks. Participants were randomized to mindfulness-based group intervention, group discussion, or health education. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Perinatal Anxiety
What is being tested?
Group Mindfulness Intervention, Group Discussion and Routine Health Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
356 participants
Where
1 siteChina
Study dates
21 Sep 2021to 1 Oct 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Pregnant women at 20 to 30 gestational weeks.
  • No obvious pregnancy complications.
  • Able to complete questionnaires independently.
  • Willing to participate in the study and able to complete the 8-week intervention.
  • Provided written informed consent.

Who cannot join

  • Self-harm behavior or suicidal tendency.
  • Current psychiatric medication use.
  • Severe mental disorder, such as schizophrenia, bipolar disorder, or organic mental disorder.
  • Severe somatic disease, such as abnormal liver or renal function, brain injury, heart disease, or epilepsy.
  • Pregnancy complications or expected inability to complete the intervention or follow-up.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Shenzhen Kangning Hospital

    Shenzhen, Guangdong, 518020

Other trials in China

About this study

Official title: Group Mindfulness Intervention for Negative Emotions in Pregnant Women and Its Effect on Attentional Bias to Pain Cues

This randomized controlled intervention study evaluated an 8-week group mindfulness intervention for pregnant women at 20 to 30 gestational weeks. Participants were randomized to mindfulness-based group intervention, group discussion, or health education. The study assessed anxiety, depressive symptoms, and fear of childbirth before and after intervention, and an exploratory subsample completed a pain dot-probe task to examine pain-related attention processing.

Being tested
Group Mindfulness Intervention, Group Discussion, Routine Health Education
Keywords
Pregnancy, Mindfulness, Depressive Symptoms, Fear of Childbirth, Pain-Related Attention, Dot-Probe Task
Medical subject headings
Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Group Mindfulness InterventionBehavioural

    The intervention consisted of eight weekly 60-minute offline group sessions. Each group included 12 to 20 participants. Sessions covered mindfulness theory, mindful breathing, body scan, mindful eating, sitting meditation, walking meditation, mindful stretching, and group reflection. The intervention was delivered by psychiatrists or psychological counseling professionals trained in mindfulness.

  • Group DiscussionBehavioural

    Participants attended eight weekly 60-minute offline group discussion sessions. Discussion topics included physical changes during pregnancy, emotional experiences, concerns about childbirth, and adaptation to daily life. The facilitator maintained group order and timing but did not provide structured psychological techniques or professional psychological guidance.

  • Routine Health EducationBehavioural

    Participants received routine outpatient health education once weekly for 8 weeks. Each session lasted approximately 15 to 20 minutes and covered antenatal health care, precautions for prenatal visits, diet, and rest. No group psychological intervention was provided.

Study groups in NCT07757243
Study groupRoleWhat they receive
Group Mindfulness InterventionExperimentalParticipants received an 8-week offline group mindfulness intervention in groups of 12 to 20. Sessions were conducted once weekly for 60 minutes by trained psychiatrists or psychological counseling professionals.
Receives: Behavioral: Group Mindfulness Intervention
Group DiscussionActive comparatorParticipants attended an 8-week offline group discussion program in groups of 12 to 20, with one 60-minute session each week.
Receives: Behavioral: Group Discussion
Health EducationActive comparatorParticipants received routine outpatient health education once weekly for 8 weeks, with each session lasting approximately 15 to 20 minutes.
Receives: Behavioral: Routine Health Education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in anxiety symptoms

    Self-Rating Anxiety Scale (SAS) Anxiety symptoms were assessed using the 20-item Zung Self-Rating Anxiety Scale (SAS). Each item is rated from 1 to 4. The raw total score ranges from 20 to 80 and is multiplied by 1.25 and rounded to obtain a standard score ranging from 25 to 100. The minimum possible standard score is 25 and the maximum is 100. Higher scores indicate more severe anxiety symptoms. A standard score of 50 or higher indicates the presence of anxiety symptoms. The standard score was used in the analysis.

    Measured: Baseline and immediately after the 8-week intervention

  2. Change in depressive symptoms

    Self-Rating Depression Scale (SDS) Depressive symptoms were assessed using the 20-item Zung Self-Rating Depression Scale (SDS). Each item is rated from 1 to 4. The raw total score ranges from 20 to 80 and is multiplied by 1.25 and rounded to obtain a standard score ranging from 25 to 100. The minimum possible standard score is 25 and the maximum is 100. Higher scores indicate more severe depressive symptoms. A standard score of 53 or higher indicates the presence of depressive symptoms. The standard score was used in the analysis.

    Measured: Baseline and immediately after the 8-week intervention

  3. Change in fear of childbirth

    Childbirth Attitudes Questionnaire (CAQ) Fear of childbirth was assessed using the 16-item Childbirth Attitudes Questionnaire (CAQ). Each item is rated from 1 to 4, producing a total score ranging from 16 to 64. The minimum possible total score is 16 and the maximum is 64. Higher scores indicate greater fear of childbirth. Scores of 16-27 indicate no fear, 28-39 mild fear, 40-51 moderate fear, and 52-64 severe fear. A total score of 28 or higher indicates the presence of fear of childbirth. The total score was used in the analysis.

    Measured: Baseline and immediately after the 8-week intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Aug 2026
  2. Study start21 Sep 2021
  3. Primary completion1 Oct 2022
  4. Study completion1 Oct 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
356 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07757243
Sponsor's protocol ID
LL2021072261
Other IDs
JCYJ20230807142359032
Status last verified
Sep 2026
First submitted
6 Aug 2026
Last updated
11 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Group Mindfulness Intervention, Group Discussion and Routine Health Education in people with Perinatal Anxiety, run by Shenzhen Kangning Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in anxiety symptoms (time frame: Baseline and immediately after the 8-week intervention). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in